HomeGALT • NASDAQ
add
Galectin Therapeutics Inc. Common Stock
Previous close
$1.42
Day range
$1.28 - $1.41
Year range
$0.73 - $3.78
Market cap
83.40M USD
Avg Volume
258.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.43M | 29.99% |
Net income | -11.97M | -19.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.12M | -41.08% |
Total assets | 17.50M | -37.96% |
Total liabilities | 120.56M | 36.32% |
Total equity | -103.07M | — |
Shares outstanding | 63.18M | — |
Price to book | -0.85 | — |
Return on assets | -133.73% | — |
Return on capital | -406.68% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -11.97M | -19.71% |
Cash from operations | -12.79M | -172.03% |
Cash from investing | — | — |
Cash from financing | 851.00K | -91.49% |
Net change in cash | -11.94M | -325.37% |
Free cash flow | -9.21M | -429.42% |
About
Founded
2000
Headquarters
Website
Employees
15
